/akn/my/act/pub/2019/108

PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31

The full official text, structured for quick navigation. Copy any provision or jump straight to a section.

Open source PDF
Type
P.U. (B)
Status
In force
Enacted
2019
Sections
2

Quick answer

About this p.u. (b)

PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 is Malaysia P.U. (B), cited as P.U. (B) 108 2019, currently marked in force and first recorded in 2019.

Opening note

Preamble

Suggest a correction
  1. PADA menjalankan kuasa yang diberikan oleh peraturan 31 Peraturan-Peraturan Kawalan Dadah dan Kosmetik 1984 [P.U. (A) 223/1984], Menteri, setelah berunding dengan Pihak Berkuasa, mengecualikan My Vet Care Sdn. Bhd. daripada pemakaian subperaturan 7(1) berhubung dengan penjualan, pembekalan, pengimportan dan pemilikan keluaran veterinar sebagaimana yang diperihalkan dalam Jadual berkuat kuasa mulai 1 Mac 2019 hingga 31 Disember 2021 tertakluk kepada syarat yang berikut:

(a)

keluaran itu hendaklah diimport hanya daripada pengilang yang dinyatakan dalam Jadual;

Suggest a correction

(b)

keluaran itu hendaklah dijual, dibekalkan dan diimport tidak melebihi kuantiti yang dinyatakan dalam Jadual;

Suggest a correction

(c)

keluaran itu hendaklah diimport hanya bagi maksud dan kegunaan doktor veterinar berdaftar dan dibekalkan dan dijual semata-mata kepada doktor veterinar berdaftar;

Suggest a correction

(d)

suatu salinan borang import Kastam mengenai keluaran itu hendaklah dihantar dalam masa tiga puluh hari dari tarikh pengimportan kepada

Pengarah Kanan Perkhidmatan Farmasi, Kementerian Kesihatan bagi tiap-tiap pengimportan; dan

Suggest a correction

(e)

suatu laporan mengenai penjualan, pembekalan, pengimportan dan pemilikan keluaran itu hendaklah dihantar kepada Pengarah Kanan

Perkhidmatan Farmasi, Kementerian Kesihatan pada tiap-tiap bulan tidak lewat daripada lima belas hari bulan pada bulan yang berikutnya.

P.U. (B) 108 3

Suggest a correction

Jadual

Suggest a correction

JADUAL

Keluaran Yang Dikecualikan

Nama Keluaran

Kuantiti

Pengilang 1.

Thyforon (200mcg)

tablet berperisa untuk anjing

2,500,000

biji tablet

Eurovet Animal Health

BV, Belanda

2.

Thyforon (400mcg)

tablet berperisa untuk anjing

2,500,000

biji tablet

Eurovet Animal Health

BV, Belanda 3.

Cardisure (1.25mg)

tablet berperisa untuk anjing

700,000

biji tablet

Eurovet Animal Health

BV, Belanda 4.

Cardisure (2.5mg)

tablet berperisa untuk anjing

700,000

biji tablet

Eurovet Animal Health

BV, Belanda 5.

Cardisure (5mg)

tablet berperisa untuk anjing

700,000

biji tablet

Eurovet Animal Health

BV, Belanda 6.

Cardisure (10mg)

tablet berperisa untuk anjing

700,000

biji tablet

Eurovet Animal Health

BV, Belanda

7.

Vetoryl (10mg)

kapsul keras untuk anjing

432,000

biji kapsul

Dechra Limited,

United Kingdom 8.

Vetoryl (30mg)

kapsul keras untuk anjing 432,000

biji kapsul

Dechra Limited,

United Kingdom

9.

Vetoryl (60mg)

kapsul keras untuk anjing 432,000

biji kapsul

Dechra Limited,

United Kingdom

10.

Felimazole (2.5mg)

tablet salut untuk kucing

1,000,000

biji tablet

Dechra Limited,

United Kingdom

P.U. (B) 108 4

11.

Felimazole (5mg)

tablet salut untuk kucing

1,000,000

biji tablet

Dechra Limited,

United Kingdom

Bertarikh 28 Januari 2019

[KKM.R.600-1/3/72 Jld. 2 (6); PN(PU2)269A/V]

DATUK SERI DR. DZULKEFLY BIN AHMAD

Menteri Kesihatan

P.U. (B) 108 5

SALE OF DRUGS ACT 1952

CONTROL OF DRUGS AND COSMETICS REGULATIONS 1984

NOTIFICATION OF EXEMPTION UNDER REGULATION 31

IN exercise of the powers conferred by regulation 31

of the

Control of Drugs and Cosmetics Regulations 1984 [P.U. (A) 223/1984], the Minister, after consultation with the Authority, exempts My Vet Care Sdn. Bhd. from the application of subregulation 7(1) in relation to the sale, supply, importation and possession of the veterinary products as described in the Schedule with effect from 1 March 2019

to 31 December 2021 subject to the following conditions:

(a)

the products shall be imported only from the manufacturer as specified in the Schedule;

(b)

the products shall be sold, supplied and imported not exceeding the quantity specified in the Schedule;

(c)

the products shall be imported only for the purposes and use of a registered veterinary surgeon and supplied and sold solely to a registered veterinary surgeon;

(d)

a copy of the Custom’s import form for every importation of the products shall be sent within thirty days from the date of importation to the Senior

Director of Pharmaceutical Services, Ministry of Health; and

(e)

a report on the sale, supply, importation and possession of the products shall be sent to the Senior Director of Pharmaceutical Services, Ministry of

Health every month not later than the fifteenth of the following month.

P.U. (B) 108 6

Jadual

Suggest a correction

Exempted Products

Product Name

Quantity

Manufacturer 1.

Thyforon (200mcg)

flavoured tablets for dogs

2,500,000

tablets

Eurovet Animal Health

BV, The Netherlands

2.

Thyforon (400mcg)

flavoured tablets for dogs

2,500,000

tablets

Eurovet Animal Health

BV, The Netherlands

3.

Cardisure (1.25mg)

flavoured tablets for dogs

700,000

tablets

Eurovet Animal Health

BV,The Netherlands

4.

Cardisure (2.5mg)

flavoured tablets for dogs

700,000

tablets

Eurovet Animal Health

BV, The Netherlands

5.

Cardisure (5mg)

flavoured tablets for dogs

700,000

tablets

Eurovet Animal Health

BV, The Netherlands

6.

Cardisure (10mg)

flavoured tablets for dogs

700,000

tablets

Eurovet Animal Health

BV, The Netherlands

7.

Vetoryl (10mg)

hard capsules for dogs

432,000

capsules

Dechra Limited,

United Kingdom

8.

Vetoryl (30mg)

hard capsules for dogs

432,000

capsules

Dechra Limited,

United Kingdom

9.

Vetoryl (60mg)

hard capsules for dogs

432,000

capsules

Dechra Limited,

United Kingdom 10.

Felimazole (2.5mg)

coated tablets for cats

1,000,000

tablets

Dechra Limited,

United Kingdom

P.U. (B) 108 7 11.

Felimazole (5mg)

coated tablets for cats

1,000,000

tablets

Dechra Limited,

United Kingdom

Dated 28 January 2019

[KKM.R.600-1/3/72 Jld. 2 (6); PN(PU2)269A/V]

DATUK SERI DR. DZULKEFLY BIN AHMAD

Minister of Health

Common questions

What is PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31?
PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 is Malaysia P.U. (B), cited as P.U. (B) 108 2019, currently marked in force and first recorded in 2019.
Is PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 still in force?
Yes — PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 is currently in force.
When did PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 take effect?
PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 was first recorded in 2019.
How many schedules does PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 have?
PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 contains 2 schedules.
Where can I read the official version of PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31?
The official text of PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 is published at lom.agc.gov.my.
PEMBERITAHUAN PENGECUALIAN DI BAWAH PERATURAN 31 (2019, No. 108)